News

Dr. Timothy Brown

Urology of Central Pennsylvania extends our congratulations to our own Dr. Timothy Brown on his recognition as one of Pennsylvania Medical Society’s (PAMED’s) Top Physicians Under 40 for 2019 — an award that honors early career physician leaders. Dr. Brown will be recognized at the award ceremony on October 25.

 Over the years, two other of Urology of Central Pennsylvania’s fine physicians have earned this special recognition – Dr. Vanessa Elliot in 2018 and Dr. Thomas Clements in 2017.

This is Nurse’s Week and we are also recognizing it as our “Surgical Services Week” at our ASC (Ambulatory Surgery Center).

We applaud our ASC Team’s efforts! Everyone who works at the UCPA ASC is committed and dedicated to making this experience as efficient and as pleasant as possible for each patient and their unique needs. We offer cost effective, high quality and state of the art services at our urology specific ASC with experienced, knowledgeable and caring staff. We are very fortunate to have some of the most trusted and talented staff at our ASC.

We appreciate the positive difference they make each and every day! THANK YOU!

• Urology of Central PA is committed to provide the most advanced, accessible and responsive urologic care in Central Pennsylvania.
• In the best interest of our patients, Urology of Central PA decided to sell the Prostate Cancer Center, a division of our practice, to UPMC Pinnacle in January 2019.
• Urology of Central PA remains an independent medical practice.
• Urology of Central PA chose UPMC Pinnacle to purchase the Prostate Cancer Center to best ensure the advancement and accessibility of prostate cancer care in the region.
• The Prostate Cancer Center is a state-of-the-art facility staffed by highly-skilled specialists who have decades of invaluable experience treating prostate cancer.
• The Prostate Cancer Center almost exclusively treats prostate cancer patients using external beam radiation therapy.
  • The Prostate Cancer Center uses the latest technology in treating prostate cancer.
  • Radiation therapy includes both Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).
• As a result, a Dr. David Salinger and other Prostate Cancer Center associates became employees of UPMC Pinnacle.
• The Prostate Cancer Center continues to be located in the same building as Urology of Central PA at 100 Corporate Circle Drive, Camp Hill.
• The purchase of the Prostate Cancer Center will provide UCPA and UPMC Pinnacle increased opportunities to offer preventative care, partner closely on prostate cancer services, and provide more/varied/different treatment options for patients.
• Urology of Central PA remains deeply committed to prostate cancer care and accessible, responsive treatment. We will still meet our community’s need for high-quality, convenient, cost-efficient urologic and prostate cancer care.
• Patients will continue to have access to the UCPA-hosted support group that meets every third Thursday of every other month (February, April, June, August. October & December).
• Patients will still have access to free prostate cancer screenings (PSA and DRE).
• Maintaining our relationships with ZERO – The End of Prostate Cancer, the PA Prostate Cancer Coalition, and the Bladder Cancer Advocacy Network (BCAN) remains important to Urology of Central PA.

Urology of Central Pennsylvania thanks our amazing staff. Our staff make a difference every day and we extend our sincere appreciation today, Administrative Professionals Day!

The staff at Urology of Central Pennsylvania do a lot to help our practice and physicians serve our patients well.

Today, we would like to recognize our Patient Service Representatives in our Patient Assistance Center (PAC). These are the hard-working people you speak with when calling to schedule appointments, ask questions, and check-in and check-out. Thank you to our Medical Secretaries and Schedulers who schedule procedures in our Surgery Center (ASC) or at the hospitals and also schedule imaging exams (CT, MRI, Ultrasound, etc.). Many thanks also to the staff in Medical Records and our Billing & Administrative team (HR, Purchasing, and Information Technology). THANK YOU for going above and beyond each day!

Earlier we shared a message regarding Merck’s anticipated TICE BCG supply constraints due to an increasing global demand for the product.

To minimize disruption to patient care, Merck (the sole supplier of BCG to the United States) announced an immediate change to their TICE BCG distribution model, and in January, ceased all drop shipments and began allocating TICE BCG exclusively to wholesalers and distributors based on product supply and historical purchasing patterns. Wholesalers and distributors in turn, began utilizing the same allocation model to fulfill customer orders directly; therefore, please contact your wholesaler should you have any questions about your allotment.

Although Merck is exploring options to increase their production of TICE BCG, they expect this global supply constraint to continue throughout 2019.